Psychiatry

814 soru

Soru 781Soru →

A 24-year-old man is diagnosed with schizophrenia after a 9-month history of auditory hallucinations, disorganized speech, and persecutory delusions. He has no significant past medical history and his urine toxicology screen is negative. His psychiatrist is developing a comprehensive pharmacological management plan to address his symptoms. The physician considers the various stages of psychopharmacological treatment, from the initial presentation to the potential development of severe refractoriness. Arrange the following therapeutic steps in the correct sequential order for the standard stepwise management of this patient's illness, starting with the initial intervention.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence for the pharmacological management of schizophrenia is: initial trial of a first-line antipsychotic, followed by a trial of a different first-line antipsychotic, then initiation of clozapine for treatment resistance, and finally augmentation of clozapine if symptoms persist.
The standard treatment algorithm for schizophrenia involves sequential trials to balance symptom control with medication side effects. Initially, a first-line agent is trialed for 4 to 6 weeks. If this fails, a second first-line agent with a different profile is trialed. Failure of two adequate trials defines treatment-resistant schizophrenia, for which clozapine is the most effective evidence-based treatment. If a patient remains symptomatic despite an adequate clozapine trial, augmentation strategies such as ECT or adding another antipsychotic are indicated.

Adım Adım Çözüm

1
Identify the initial standard of care for a newly diagnosed patient.
Initiation of an oral first-line antipsychotic as initial monotherapy.
First- and second-generation antipsychotics (excluding clozapine) are the standard initial therapies due to their favorable balance of efficacy and side effects.
2
Determine the next appropriate step if the first medication fails.
Switch to a different first-line antipsychotic as a second monotherapy trial.
Before declaring treatment resistance, a patient must fail two adequate trials of different antipsychotic medications.
3
Identify the gold standard treatment for true treatment-resistant schizophrenia.
Initiation of clozapine therapy with ANC monitoring.
Clozapine is specifically indicated for patients who have failed at least two antipsychotic trials, owing to its superior efficacy in refractory cases despite its risk of agranulocytosis.
4
Determine the final intervention for patients who do not fully respond to clozapine.
Augmentation of clozapine with ECT or an additional psychotropic agent.
When clozapine monotherapy is insufficient, augmenting the regimen is the final pharmacological and somatic line of defense.

Anahtar Kavram

Stepwise psychopharmacological management of schizophrenia and the definition of treatment-resistant schizophrenia
Soru 782Soru →

A 29-year-old woman is brought to the emergency department by her partner due to worsening confusion, extreme restlessness, and tremors. Her temperature is 39.4∘C39.4^{\circ}\text{C} (102.9∘F102.9^{\circ}\text{F}), heart rate is 132/min132\text{/min}, and blood pressure is 164/98 mm Hg164/98\text{ mm Hg}. Physical examination reveals profuse diaphoresis, mydriasis, hyperreflexia, and sustained clonus in the bilateral lower extremities. Her medical history is significant for major depressive disorder treated with sertraline. Two days ago, she began taking an over-the-counter dextromethorphan syrup for a cough. Arrange the following therapeutic interventions in the most appropriate sequential order for managing this patient's condition, starting from the immediate first step to treatments reserved for progressively severe or refractory toxicity.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence of interventions is: Discontinue all serotonergic medications, followed by administering intravenous fluids and lorazepam, then administering oral cyproheptadine, and finally, if necessary, initiating endotracheal intubation and non-depolarizing neuromuscular blockade.
The correct sequence follows the standard stepwise algorithm for managing serotonin syndrome. The immediate priority is discontinuing the offending serotonergic agents. If symptoms persist, supportive care with intravenous fluids and benzodiazepines (e.g., lorazepam) is initiated to control agitation, lower blood pressure, and reduce heart rate. If the patient's symptoms are moderate to severe and refractory to benzodiazepines, cyproheptadine (a 5-HT2A receptor antagonist) is administered. Finally, in critically severe cases presenting with life-threatening hyperthermia (e.g., >41.1∘C> 41.1^{\circ}\text{C}) and extreme rigidity that threatens respiratory function, endotracheal intubation and non-depolarizing neuromuscular blockade are required to prevent fatal complications.

Adım Adım Çözüm

1
Diagnose the patient's condition based on the clinical presentation.
The combination of autonomic instability, altered mental status, and neuromuscular irritability (hyperreflexia, clonus) in the context of taking sertraline and dextromethorphan strongly indicates serotonin syndrome.
Accurate diagnosis is required to determine the appropriate treatment algorithm and anticipate potential complications.
2
Determine the immediate first step in management.
The immediate priority is to stop the offending agents (sertraline and dextromethorphan).
Toxicity will continue or worsen as long as the precipitating serotonergic medications are present.
3
Identify the standard first-line supportive medical treatments.
Supportive care with intravenous fluids and benzodiazepines (such as lorazepam) should be initiated to control agitation and decrease muscle hyperactivity.
Benzodiazepines help manage the hyperdynamic vitals and muscle contractions, serving as the standard initial medical therapy for mild to moderate cases.
4
Identify the next pharmacological step if supportive care fails.
Cyproheptadine should be administered if symptoms are refractory to initial supportive measures.
Cyproheptadine is a specific 5-HT2A receptor antagonist that acts as an antidote, but it is typically reserved for moderate to severe cases not responding adequately to benzodiazepines.
5
Determine the treatment of last resort for extreme, life-threatening toxicity.
Intubation and non-depolarizing neuromuscular blockade are reserved for critically severe cases.
Paralysis prevents further heat generation from extreme muscle rigidity, which is crucial for treating severe hyperthermia (e.g., temperature >41.1∘C> 41.1^{\circ}\text{C}) and preventing rhabdomyolysis.

Anahtar Kavram

The management of serotonin syndrome follows a stepwise algorithmic approach: immediate discontinuation of serotonergic agents, supportive care with benzodiazepines, administration of the serotonin antagonist cyproheptadine for refractory cases, and finally intubation/paralysis for life-threatening hyperthermia.
Soru 783Soru →

Seeking assistance to achieve sobriety, a 48-year-old male construction worker presents to an addiction medicine clinic. He reports consuming a half-liter of vodka daily and feels unable to quit relying on willpower alone. His medical history is notable for a previous heroin addiction, which has been in stable remission for three years via daily buprenorphine-naloxone therapy. He was also diagnosed with chronic hepatitis C two years ago but has not received antiviral treatment. Vital signs are within normal limits. Physical examination shows a calm, cooperative patient with no tremors, diaphoresis, or autonomic instability.

Laboratory evaluation reveals:

TestResultReference Range
Aspartate aminotransferase (AST)120 U/L8-40 U/L
Alanine aminotransferase (ALT)95 U/L7-56 U/L
Total bilirubin1.1 mg/dL0.1-1.2 mg/dL
Serum creatinine0.8 mg/dL0.7-1.3 mg/dL

The patient requests a medication to help reduce his alcohol consumption. Which of the following is the most appropriate pharmacotherapy for this patient?

Cevabı ve açıklamayı göster

Cevap: Acamprosate

Cevap

Acamprosate
The most appropriate medication for this patient is acamprosate. This patient is seeking maintenance pharmacotherapy for alcohol use disorder to prevent relapse. The two primary first-line options are naltrexone and acamprosate. However, naltrexone is a mu-opioid receptor antagonist and is absolutely contraindicated in patients actively taking opioids, including partial agonists like buprenorphine, because it will immediately precipitate acute opioid withdrawal. Furthermore, naltrexone and disulfiram both carry risks of hepatotoxicity and should be avoided in patients with active liver inflammation (indicated by this patient's elevated AST and ALT secondary to hepatitis C). Acamprosate is primarily excreted unchanged by the kidneys and does not interact with the hepatic cytochrome P450 system or opioid receptors. Given this patient's normal serum creatinine (0.8 mg/dL0.8\text{ mg/dL}), acamprosate is safe and represents the optimal choice.

Adım Adım Çözüm

1
Identify the patient's primary clinical need and timeline.
The patient is seeking long-term maintenance pharmacotherapy to reduce alcohol cravings, not acute withdrawal management.
Establishing the clinical goal rules out acute detoxification agents like benzodiazepines.
2
Review the patient's medication history for potential drug interactions.
The patient is currently on buprenorphine-naloxone for opioid use disorder.
First-line agents for alcohol use disorder include naltrexone and acamprosate. Naltrexone is an opioid antagonist and will precipitate severe withdrawal in patients on opioid therapies.
3
Evaluate laboratory results to identify metabolic contraindications.
The patient has active hepatitis C with elevated AST and ALT, but normal serum creatinine.
Liver dysfunction contraindicates hepatotoxic medications like disulfiram and often naltrexone. Acamprosate is renally excreted and is the safest choice for this patient.

Anahtar Kavram

Acamprosate is the first-line pharmacotherapy for alcohol use disorder in patients who have concurrent opioid use disorder (where naltrexone is contraindicated) or significant liver disease, provided their renal function is intact.
Soru 784Soru →

A 19-year-old man is brought to the emergency department by his college roommate due to increasingly bizarre behavior. The roommate reports that for the past 21 days, the patient has been highly agitated, refusing to attend classes, and has barricaded himself in their shared dorm room. The patient confidently claims that foreign intelligence agents are tracking his movements through the campus Wi-Fi network. During the interview, the patient appears guarded, frequently pauses to whisper to the empty corner of the room, and his speech frequently derails into unrelated topics. His medical history is unremarkable, and he takes no medications. Vital signs and physical examination are within normal limits. A comprehensive urine toxicology screen is negative. Which of the following is the most likely diagnosis?

Cevabı ve açıklamayı göster

Cevap: Brief psychotic disorder

Cevap

Brief psychotic disorder
The patient is presenting with an acute onset of delusions, auditory hallucinations, and disorganized speech. These are core positive symptoms of psychosis. The critical diagnostic feature in this vignette is the duration of symptoms, which the roommate states is exactly 21 days (3 weeks). Brief psychotic disorder is defined by the sudden onset of at least one core psychotic symptom (delusions, hallucinations, or disorganized speech) that lasts for at least 1 day but less than 1 month, with an eventual full return to the premorbid level of functioning. Since the patient's symptoms have been present for less than 1 month and toxicology is negative, brief psychotic disorder is the most accurate diagnosis.

Adım Adım Çözüm

1
Identify the primary psychiatric symptoms presented in the vignette.
The patient demonstrates delusions (believing agents are tracking him), auditory hallucinations (whispering to an empty corner), and disorganized speech (derailment).
Establishing the presence of core positive psychotic symptoms is the first requirement for diagnosing a schizophrenia spectrum disorder.
2
Determine the exact duration of the psychotic symptoms.
The symptoms have been present for exactly 21 days (3 weeks).
The duration of symptoms is the critical distinguishing factor between the primary psychotic disorders.
3
Rule out secondary causes of the psychotic episode.
The negative urine toxicology screen and normal physical examination lower the likelihood of a substance-induced or medical cause.
Primary psychiatric conditions are diagnoses of exclusion.
4
Synthesize the symptom profile and timeline to reach the final diagnosis.
Positive psychotic symptoms lasting between 1 day and 1 month confirms the diagnosis of brief psychotic disorder.
This timeline specifically excludes schizophreniform disorder and schizophrenia.

Anahtar Kavram

The diagnostic duration criteria that differentiate brief psychotic disorder (<1 month), schizophreniform disorder (1-6 months), and schizophrenia (>6 months).
Soru 785Soru →

A patient with well-controlled depression is evaluated during a same-day appointment for acute-onset agitation, sweating, and muscle spasms. The 45-year-old male states these symptoms began roughly 12 hours ago. His medical history includes major depressive disorder, for which he takes citalopram daily. Two days ago, he strained his lower back while moving heavy boxes and received a prescription from a local urgent care facility. Vital signs show a temperature of 38.6°C (101.5°F), blood pressure of 162/94 mm Hg, and heart rate of 115/min. On physical examination, the patient appears visibly restless and diaphoretic. Neurological assessment reveals bilateral ocular clonus, generalized hyperreflexia, and sustained ankle clonus. Which of the following medications was most likely prescribed for this patient's back injury?

Cevabı ve açıklamayı göster

Cevap: Tramadol

Cevap

Tramadol
Tramadol has a dual mechanism of action: it acts as a weak mu-opioid receptor agonist and also inhibits the presynaptic reuptake of serotonin and norepinephrine. When a patient already taking a selective serotonin reuptake inhibitor (SSRI) like citalopram is prescribed tramadol, the synergistic increase in intrasynaptic serotonin can precipitate serotonin syndrome. This toxidrome is classically characterized by the triad of autonomic hyperactivity (tachycardia, diaphoresis, hyperthermia), altered mental status (agitation), and distinct neuromuscular abnormalities (hyperreflexia, sustained clonus, and ocular clonus).

Adım Adım Çözüm

1
Analyze the patient's acute clinical presentation.
The patient exhibits autonomic instability (fever, tachycardia, hypertension, diaphoresis), altered mental status (agitation), and neuromuscular irritability (hyperreflexia, ocular and ankle clonus).
These findings form the classic clinical triad of serotonin syndrome.
2
Review the patient's baseline medications.
The patient takes citalopram, a selective serotonin reuptake inhibitor (SSRI).
SSRIs increase baseline serotonergic tone and are the most common foundation for serotonin syndrome when combined with other serotonergic drugs.
3
Evaluate the options for a precipitating agent.
Identify which of the listed medications prescribed for back pain possesses serotonergic properties.
An interacting serotonergic medication is required to trigger this acute toxicity.
4
Select the correct medication.
Tramadol is chosen because it inhibits serotonin reuptake in addition to its primary analgesic effects.
Adding tramadol to an SSRI leads to a synergistic and dangerous increase in synaptic serotonin, precipitating the observed crisis.

Anahtar Kavram

Serotonin syndrome is a potentially life-threatening condition characterized by autonomic hyperactivity, mental status changes, and neuromuscular excitability. It is often precipitated by combining an SSRI with other serotonergic medications, such as tramadol, MAOIs, or linezolid.
Soru 786Soru →

Match each clinical vignette describing a patient's therapeutic intervention to the most appropriate psychological therapy modality.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 28-year-old patient with frequent self-harm behaviors, chronic feelings of emptiness, and a pattern of intense, unstable relationships engages in a skills-based therapy to improve distress tolerance and emotion regulation.
A 35-year-old veteran with intrusive flashbacks and hypervigilance undergoes a structured therapy that pairs recounting the traumatic narrative with guided, bilateral sensory stimulation.
A 41-year-old man with major depressive disorder participates in a short-term, goal-oriented intervention focused on identifying maladaptive automatic thoughts and scheduling pleasant activities.
A 52-year-old patient who heavily consumes alcohol expresses a desire to cut down but feels unable to do so. The provider uses a non-judgmental approach to explore this ambivalence and elicit the patient's own reasons for change.
A 24-year-old woman with severe obsessive-compulsive disorder is systematically subjected to her contamination triggers while being actively prevented from engaging in her hand-washing rituals.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct pairings align each patient's clinical presentation and described therapeutic technique with its specific modality: emotion dysregulation and self-harm with Dialectical behavioral therapy; trauma narrative and bilateral stimulation with Eye movement desensitization and reprocessing; depressive cognitive distortions and behavioral activation with Cognitive behavioral therapy; substance ambivalence with Motivational interviewing; and obsession triggers with compulsion blocking with Exposure and response prevention.
Each psychological therapy utilizes specific techniques tailored to particular psychiatric disorders. Dialectical behavioral therapy is specifically tailored for borderline personality disorder, targeting self-harm and emotional lability. Eye movement desensitization and reprocessing utilizes bilateral stimulation specifically for trauma processing in PTSD. Cognitive behavioral therapy focuses on restructuring maladaptive thoughts and scheduling activities, making it first-line for depression and anxiety. Motivational interviewing is a patient-centered approach uniquely structured to resolve ambivalence in substance use and behavioral changes. Exposure and response prevention is a highly specific behavioral therapy for OCD that breaks the reinforcing cycle of obsessions and compulsions.

Adım Adım Çözüm

1
Identify the underlying psychiatric condition or prominent symptoms described in each patient vignette.
Vignette 1 describes borderline personality disorder. Vignette 2 describes PTSD. Vignette 3 describes major depressive disorder. Vignette 4 describes a substance use disorder. Vignette 5 describes obsessive-compulsive disorder.
Psychological therapies are highly specific to the pathophysiology and symptom clusters of individual psychiatric disorders.
2
Identify the core therapeutic mechanism or technique being utilized in each scenario.
The techniques are distress tolerance (Vignette 1), bilateral stimulation (Vignette 2), addressing maladaptive thoughts (Vignette 3), exploring ambivalence (Vignette 4), and trigger exposure without ritual completion (Vignette 5).
Matching the technique to the theoretical framework of the therapy confirms the correct modality.
3
Correlate the diagnosis and technique to the correct evidence-based psychological therapy.
The techniques map directly to DBT, EMDR, CBT, Motivational Interviewing, and ERP, respectively.
This confirms the correct pairing for each clinical presentation.

Anahtar Kavram

Indications and core techniques of evidence-based psychological therapies.
Soru 787Soru →

A 20-year-old man is brought to the emergency department by the police after he was found wandering on a busy highway, shouting at passing vehicles. In the emergency department, he is highly agitated, pacing the room, and stating that the cars are emitting radio waves to control his mind. His speech is disorganized, and he frequently pauses as if responding to unseen stimuli. The patient's parents are contacted and arrive at the hospital. They report that these severe, bizarre behaviors began only 2 weeks ago. However, they note that for the past 9 months, he has undergone a significant change. Previously a sociable and high-achieving college student, he gradually stopped seeing his friends, dropped out of his classes, and spent most of his days sitting in his darkened bedroom showing very little emotion. His medical history is unremarkable, and a urine toxicology screen is negative. Which of the following is the most likely diagnosis?

Cevabı ve açıklamayı göster

Cevap: Schizophrenia

Cevap

Schizophrenia
The diagnosis of schizophrenia requires the presence of at least two active-phase symptoms (e.g., delusions, hallucinations, disorganized speech) for a significant portion of a 1-month period, along with continuous signs of the disturbance persisting for at least 6 months. Crucially, this 6-month period must include prodromal, active, and residual phases. In this scenario, the patient has a 9-month history of prodromal negative symptoms (social withdrawal, lack of emotion, functional decline) followed by a 2-week active phase of frank psychosis (delusions, hallucinations, disorganized speech). Because the total duration of his illness exceeds 6 months, schizophrenia is the correct diagnosis.

Adım Adım Çözüm

1
Identify the active phase symptoms.
The patient exhibits delusions, auditory hallucinations, and disorganized speech that have been present for 2 weeks.
Establishing the presence of active psychosis is the first step in differentiating psychotic disorders.
2
Identify any preceding symptoms indicating a prodromal phase.
The patient had a 9-month period of social withdrawal, avolition, and flat affect prior to the onset of acute psychosis.
Prodromal symptoms (often negative symptoms) must be accounted for when calculating the total duration of the illness.
3
Calculate the total duration of the illness.
9 months of prodromal symptoms + 2 weeks of active symptoms = total duration of > 9 months.
Total duration (prodromal + active + residual) is the key differentiator among brief psychotic disorder, schizophreniform disorder, and schizophrenia.
4
Apply DSM-5 diagnostic criteria based on the timeline.
Because the total duration is greater than 6 months, the correct diagnosis is schizophrenia.
Schizophrenia requires continuous signs of the disturbance for at least 6 months.

Anahtar Kavram

The DSM-5 diagnostic criteria for schizophrenia require continuous signs of the disturbance for at least 6 months, which includes prodromal, active, and residual phases.
Soru 788Soru →

During a routine oncology follow-up, a 52-year-old female patient reports an eight-week history of persistently low mood, loss of interest in activities she previously enjoyed, early morning awakenings, and severe fatigue. She has a history of estrogen receptor-positive breast cancer that was treated with surgical resection and radiation therapy two years ago. She is currently maintained on daily tamoxifen to prevent cancer recurrence. Vital signs include a blood pressure of 124/78 mm Hg124/78 \text{ mm Hg}, pulse of 72/min72/\text{min}, and temperature of 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}). Mental status examination reveals a tearful, blunted affect and psychomotor retardation, with no evidence of psychosis or suicidal ideation. A diagnosis of major depressive disorder is established, and pharmacotherapy is considered. Which of the following antidepressants should be strictly avoided in this patient to prevent a reduction in the efficacy of her antineoplastic therapy?

Cevabı ve açıklamayı göster

Cevap: Paroxetine

Cevap

Paroxetine
Paroxetine is a strong inhibitor of the cytochrome P450 2D6 (CYP2D6) enzyme. Tamoxifen is a prodrug that relies heavily on CYP2D6 for conversion into its primary active metabolite, endoxifen, which exerts the necessary therapeutic anti-estrogen effects. Co-administration of strong CYP2D6 inhibitors (such as paroxetine or fluoxetine) with tamoxifen prevents this conversion, significantly decreasing endoxifen levels and increasing the patient's risk for breast cancer recurrence. Therefore, paroxetine must be strictly avoided in patients undergoing tamoxifen therapy.

Adım Adım Çözüm

1
Identify the patient's current medication and its required metabolic pathway.
The patient is taking tamoxifen, a selective estrogen receptor modulator (SERM). Tamoxifen is a prodrug that must be converted by the hepatic enzyme CYP2D6 into its highly active metabolite, endoxifen.
Understanding the pharmacokinetics of the patient's existing therapy is necessary to anticipate potential drug-drug interactions when adding a new agent.
2
Analyze the proposed treatment for major depressive disorder in the context of CYP2D6.
The goal is to select an antidepressant that does not inhibit CYP2D6, as inhibiting this enzyme would block the activation of tamoxifen and risk breast cancer relapse.
Certain antidepressants are potent inhibitors of CYP2D6 and represent an absolute contraindication for patients on tamoxifen.
3
Evaluate the interaction profiles of the given antidepressant options.
Paroxetine (along with fluoxetine) is a strong CYP2D6 inhibitor. Venlafaxine, desvenlafaxine, escitalopram, and mirtazapine have minimal or no CYP2D6 inhibitory effects.
Identifying the strong CYP2D6 inhibitor pinpoints the medication that must be strictly avoided.

Anahtar Kavram

Pharmacokinetic interactions between tamoxifen (a CYP2D6 substrate) and specific antidepressants (potent CYP2D6 inhibitors like paroxetine and fluoxetine).
Soru 789Soru →

A 20-year-old man is brought to the emergency department by his college roommate due to profound fatigue, severe depressed mood, and increased appetite for the past two days. The roommate reports that last week, the patient was awake for four consecutive days preparing for final exams. During that time, the patient was highly energetic, unusually talkative, and told his roommate he had "unlocked the mathematical secrets of the universe." The patient now sleeps up to 16 hours a day and complains of intensely vivid, disturbing dreams when he briefly awakens. He has no prior medical or psychiatric history and takes no prescribed medications. Vital signs are temperature 36.8°C (98.2°F), blood pressure 112/72 mm Hg, pulse 58/min, and respirations 14/min. Physical examination shows a flat affect and significant psychomotor retardation, but no focal neurological deficits. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Provide supportive care and observation

Cevap

Provide supportive care and observation
The correct next step in management is to provide supportive care and observation. This patient is exhibiting a classic presentation of stimulant (e.g., amphetamine or cocaine) withdrawal. The initial phase of prolonged wakefulness, excessive energy, and grandiosity represents acute stimulant intoxication, commonly seen in college students abusing "study drugs." The abrupt cessation of the stimulant leads to a "crash," which is characterized by profound fatigue, hypersomnolence, hyperphagia, intense and vivid unpleasant dreams, and severe depression with psychomotor retardation. Unlike alcohol or benzodiazepine withdrawal, stimulant withdrawal is not acutely life-threatening and does not require specific substitution pharmacotherapy or tapering protocols. The most appropriate management is supportive care, allowing the patient to rest and recover while monitoring closely for severe depressive symptoms or suicidal ideation.

Adım Adım Çözüm

1
Analyze the biphasic clinical presentation based on the history.
The patient had a period of prolonged wakefulness, hyperactivity, and grandiosity (intoxication), followed by a "crash" of hypersomnolence, hyperphagia, vivid dreams, and psychomotor retardation (withdrawal).
Recognizing the transition from acute intoxication to withdrawal is essential for identifying substance-related syndromes, specifically stimulant abuse.
2
Determine the appropriate intervention for the current state (stimulant withdrawal).
Stimulant withdrawal relies primarily on supportive care, as there are no FDA-approved targeted pharmacotherapies to reverse or treat the withdrawal syndrome.
Unlike alcohol or sedative withdrawal, stimulant withdrawal is not generally life-threatening, making supportive observation the safest and most effective initial step.

Anahtar Kavram

Stimulant withdrawal typically presents with a "crash" characterized by severe fatigue, hypersomnolence, hyperphagia, vivid unpleasant dreams, and depression following a period of high energy and prolonged wakefulness. Management is primarily supportive.
Soru 790Soru →

A 26-year-old man with a recent diagnosis of schizophrenia is initiated on haloperidol therapy. As his physician, you will monitor him closely for extrapyramidal symptoms (EPS). Arrange the following clinical presentations of extrapyramidal side effects in the correct chronological order based on their typical onset following the initiation of typical antipsychotic therapy, from earliest onset to latest onset.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: sustained neck contractions (acute dystonia), followed by inner restlessness (akathisia), then tremor and rigidity (parkinsonism), and finally choreoathetoid movements (tardive dyskinesia).
Extrapyramidal symptoms present in a predictable chronological sequence following the administration of dopamine D2 receptor antagonists. Acute dystonia (sustained muscle spasms) occurs earliest, within hours to days. Akathisia (inner restlessness) follows, emerging over days to weeks. Drug-induced parkinsonism (bradykinesia, rigidity, tremor) develops over weeks to months. Finally, tardive dyskinesia (involuntary choreoathetoid movements) is a late complication resulting from receptor upregulation after months to years of therapy.

Adım Adım Çözüm

1
Identify the symptom that occurs most acutely (within hours to days).
Sustained, painful muscle contractions representing acute dystonia.
Acute dystonia is an immediate reaction to D2 receptor blockade in the nigrostriatal pathway.
2
Identify the symptom that emerges subacutely, typically within days to weeks.
Intense subjective inner restlessness representing akathisia.
Akathisia generally requires several days to a few weeks of antipsychotic exposure to manifest.
3
Identify the symptom that develops over weeks to months.
Resting tremor, bradykinesia, and rigidity representing drug-induced parkinsonism.
Parkinsonism takes time to develop as the dopamine-acetylcholine balance in the basal ganglia is progressively altered.
4
Identify the late-onset complication occurring after months to years.
Involuntary choreoathetoid movements representing tardive dyskinesia.
Tardive dyskinesia is caused by dopamine receptor upregulation and supersensitivity after chronic, long-term blockade.

Anahtar Kavram

The classic chronological timeline for the development of antipsychotic-induced extrapyramidal symptoms follows the sequence: Acute dystonia (hours to days), Akathisia (days to weeks), Parkinsonism (weeks to months), and Tardive dyskinesia (months to years).
Soru 791Soru →

The natural history of schizophrenia typically unfolds over a patient's lifespan, reflecting its underlying neurodevelopmental pathology. Arrange the following characteristic clinical phases of the disorder in their correct chronological sequence of occurrence, from the earliest manifestation to the most advanced chronic stage.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence of schizophrenia progression is: Premorbid phase, Prodromal phase, Active phase, and Residual phase.
Schizophrenia follows a characteristic longitudinal trajectory. It begins with a premorbid phase of subtle developmental abnormalities, transitions into a prodromal phase of functional decline and subclinical psychotic symptoms, peaks with an active phase of florid psychosis, and eventually settles into a residual phase dominated by negative and cognitive symptoms.

Adım Adım Çözüm

1
Identify the earliest developmental stage of the illness.
The premorbid phase is placed first.
Schizophrenia is a neurodevelopmental disorder that often manifests in childhood with subtle, non-specific deficits long before psychiatric symptoms emerge.
2
Identify the transitional period immediately preceding frank psychosis.
The prodromal phase is placed second.
This phase is marked by a clear decline in baseline functioning and the onset of sub-threshold (attenuated) psychotic symptoms, usually in late adolescence.
3
Identify the stage of acute clinical presentation.
The active phase is placed third.
This represents the first true psychotic break, featuring prominent hallucinations and delusions that meet full diagnostic criteria.
4
Identify the chronic, post-acute stage of the illness.
The residual phase is placed last.
Following the resolution or treatment of the florid positive symptoms, patients typically enter a prolonged period dominated by persistent negative symptoms and cognitive impairment.

Anahtar Kavram

The chronological progression and distinct clinical phases in the natural history of schizophrenia.
Soru 792Soru →

In the emergency department setting, rapid identification of specific substance toxidromes is critical for guiding appropriate acute management and supportive care. Match each substance-related clinical state with its most characteristic physical examination findings and clinical presentation.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Phencyclidine (PCP) intoxication
MDMA (Ecstasy) intoxication
Opioid withdrawal
Inhalant intoxication

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Phencyclidine (PCP) intoxication matches with multidirectional nystagmus and diminished pain perception; MDMA intoxication matches with bruxism, hyperthermia, and hyponatremia; Opioid withdrawal matches with mydriasis, rhinorrhea, and piloerection; Inhalant intoxication matches with brief euphoria, lethargy, and a perioral rash.
Each substance produces a highly specific toxidrome. PCP acts as an NMDA receptor antagonist, uniquely causing multidirectional nystagmus. MDMA enhances serotonin, dopamine, and norepinephrine release, leading to sympathetic arousal, bruxism, and hyponatremia. Opioid withdrawal triggers an uninhibited locus coeruleus, causing severe sympathetic hyperactivity (mydriasis, piloerection, rhinorrhea). Inhalants act quickly as CNS depressants, and the chemical exposure directly damages perioral skin.

Adım Adım Çözüm

1
Identify the unique hallmark sign of PCP intoxication.
Matches with multidirectional (horizontal and vertical) nystagmus and diminished pain perception.
PCP is unique among drugs of abuse for producing prominent rotary or multidirectional nystagmus along with profound analgesia and agitation.
2
Recognize the specific sympathetic and serotonergic overdrive features of MDMA.
Matches with severe bruxism, hyperthermia, and risk of hyponatremia.
MDMA classically induces jaw clenching (bruxism), extreme hyperthermia in party settings, and hyponatremia from overhydration and SIADH.
3
Differentiate opioid withdrawal from intoxication.
Matches with mydriasis, rhinorrhea, excessive yawning, piloerection, and GI distress.
While opioid intoxication causes miosis and constipation, withdrawal causes a hyperadrenergic state resembling a severe flu, including piloerection ('cold turkey').
4
Identify the physical stigmata of inhalant abuse.
Matches with brief euphoria, lethargy, and a characteristic erythematous perioral rash.
Inhalants are highly lipophilic, causing rapid, brief intoxication. The perioral rash is caused by the drying and irritating effects of the inhaled chemicals around the mouth and nose.

Anahtar Kavram

Clinical recognition of specific substance intoxication and withdrawal toxidromes based on characteristic physical examination findings.
Tahmini Süre:1m 30s
Soru 793Soru →

A 32-year-old man is brought to the psychiatric clinic by his sister for a follow-up evaluation. The patient has a 10-month history of continuous psychiatric symptoms. According to the sister, the illness began with a 7-month period during which the patient experienced severe sadness, loss of appetite, hypersomnia, and intense feelings of worthlessness. During this same 7-month period, he also began hearing voices plotting to harm him and firmly believed his neighbors were attempting to poison his water supply. Following a medication adjustment 3 months ago, the patient's mood, appetite, and sleep completely returned to normal, and he no longer feels sad or worthless. However, over the past 3 months of euthymia, he has continued to hear voices and remains convinced that his water is poisoned. He does not use illicit substances, and a urine drug screen is negative. Which of the following is the most likely diagnosis?

Cevabı ve açıklamayı göster

Cevap: Schizoaffective disorder

Cevap

Schizoaffective disorder
The correct diagnosis is schizoaffective disorder. To meet DSM-5 criteria for this condition, a patient must experience an uninterrupted period of illness during which there is a major mood episode concurrent with active phase symptoms of schizophrenia. Crucially, the patient must also experience psychotic symptoms (delusions or hallucinations) for ≥2\ge 2 weeks in the absence of a major mood episode. Finally, the mood symptoms must be present for the majority of the total duration of the active and residual portions of the illness. This patient perfectly meets these criteria: he has a total illness duration of 10 months, with 7 months of concurrent mood and psychotic symptoms, followed by 3 months of psychosis during a period of complete euthymia. Because the mood symptoms were present for 7 out of 10 months, they account for the majority of the illness duration.

Adım Adım Çözüm

1
Establish the total duration of the patient's illness and characterize all symptom domains.
The total continuous illness duration is 10 months. Symptoms include a major depressive episode (7 months) and active psychotic symptoms including hallucinations and delusions (10 months total).
Establishing the total timeline and symptom overlap is necessary to differentiate brief, schizophreniform, and chronic psychotic disorders from mood disorders.
2
Analyze the temporal relationship between the mood symptoms and psychotic symptoms.
The patient had concurrent mood and psychotic symptoms for 7 months, followed immediately by 3 months of pure psychotic symptoms in the complete absence of any mood symptoms.
Differentiating primary mood disorders from primary psychotic disorders requires evaluating whether psychosis exists independently of mood episodes for a clinically significant duration (≥2\ge 2 weeks).
3
Synthesize the findings to apply DSM-5 diagnostic criteria for psychotic disorders.
The patient has psychosis lasting ≥2\ge 2 weeks without a mood episode, ruling out a primary mood disorder with psychotic features. Furthermore, the mood symptoms were present for the majority of the total illness duration (7 out of 10 months), pointing directly to schizoaffective disorder rather than schizophrenia.
These precise temporal features are the hallmark criteria that separate schizoaffective disorder from other conditions on the schizophrenia spectrum.

Anahtar Kavram

The diagnosis of schizoaffective disorder requires an uninterrupted period of illness featuring a major mood episode concurrent with schizophrenia symptoms, delusions or hallucinations lasting ≥2\ge 2 weeks in the absence of a major mood episode, and mood symptoms present for the majority of the total illness duration.
Soru 794Soru →

An internal medicine rapid response team is called to evaluate a 25-year-old hospitalized man for acute-onset severe agitation and chest discomfort. The patient was admitted yesterday for a soft tissue infection of the right arm and has been receiving intravenous cefazolin. When the physician arrives, the patient is pacing the room, visibly sweating, and shouting at the nursing staff. Vital signs are temperature 37.9°C (100.2°F), blood pressure 178/112 mm Hg, pulse 132/min, and respirations 24/min. Physical examination reveals bilateral mydriasis and significant diaphoresis. A friend who was visiting the patient abruptly left the room right before the episode started. An ECG demonstrates sinus tachycardia with no ST-segment changes. Which of the following is the most appropriate initial step in the pharmacologic management of this patient?

Cevabı ve açıklamayı göster

Cevap: Intravenous lorazepam

Cevap

The most appropriate initial step is to administer intravenous lorazepam.
The correct answer is intravenous lorazepam. This patient's presentation of acute severe agitation, hypertension, tachycardia, diaphoresis, and mydriasis shortly after a visitor left strongly suggests acute stimulant intoxication (e.g., cocaine or methamphetamine) acquired during his hospitalization. Benzodiazepines are the first-line pharmacotherapy for stimulant toxicity. They enhance GABA-A receptor activity, which decreases central nervous system sympathetic outflow. This effectively treats the agitation, lowers blood pressure and heart rate, and raises the seizure threshold, thereby addressing both the symptoms and the major life-threatening complications of stimulant overdose.

Adım Adım Çözüm

1
Identify the patient's clinical toxidrome based on vital signs and physical examination.
The patient exhibits severe agitation, hypertension, tachycardia, hyperthermia, diaphoresis, and mydriasis.
Recognizing the toxidrome is essential to narrow down the differential diagnosis of acute agitation and hemodynamic instability.
2
Correlate the toxidrome with the clinical context to establish the most likely diagnosis.
The acute onset of a sympathomimetic toxidrome immediately following a visit from a friend strongly points to acute illicit stimulant intoxication (e.g., cocaine or methamphetamine) acquired while in the hospital.
The context helps confirm the etiology, distinguishing it from other causes of agitation such as delirium or medication adverse effects.
3
Determine the most appropriate initial pharmacological intervention for stimulant toxicity.
Benzodiazepines, such as intravenous lorazepam, are selected to decrease central sympathetic outflow, thereby controlling agitation, lowering blood pressure and heart rate, and preventing seizures.
First-line management of stimulant intoxication relies on GABA-ergic medications to safely counteract the hyperadrenergic state without risking unopposed alpha-receptor stimulation.

Anahtar Kavram

The initial management of acute stimulant (e.g., cocaine, methamphetamine) intoxication is centered on the administration of benzodiazepines to reduce central sympathetic outflow, while strictly avoiding beta-blockers due to the risk of unopposed alpha-adrenergic stimulation.
Soru 795Soru →

A 52-year-old man with a known history of severe alcohol use disorder is brought to the emergency department by emergency medical services after being found confused and wandering in a park. On examination, he is disoriented to time and place, has horizontal nystagmus, and exhibits a wide-based, unsteady gait. He appears malnourished. Arrange the following diagnostic and therapeutic steps in the most appropriate sequential order for the acute management of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: 1) Primary assessment and capillary blood glucose measurement, 2) Intravenous thiamine administration, 3) Intravenous dextrose administration, 4) Non-contrast CT scan of the head.
The patient presents with confusion, ataxia, and nystagmus, which represents the classic clinical triad for Wernicke encephalopathy. The standard sequence of care for any patient with altered mental status begins with the primary assessment (ABCs) and a rapid capillary blood glucose check to rule out immediate life-threatening issues. Because this patient has a severe alcohol use disorder and physical signs of malnutrition and encephalopathy, high-dose intravenous thiamine must be administered next. Thiamine acts as an essential coenzyme in glucose metabolism. Therefore, thiamine must be given prior to intravenous dextrose; otherwise, the glucose load will consume the already depleted thiamine stores, worsening the encephalopathy. Finally, after the patient is metabolically stabilized and empiric therapies are administered, a non-contrast CT scan of the head is indicated to rule out occult traumatic intracranial hemorrhage, which is highly prevalent in patients with chronic alcohol use.

Adım Adım Çözüm

1
Stabilize the patient and perform rapid point-of-care testing.
Airway, breathing, and circulation are secured, and capillary blood glucose is checked to evaluate for severe hypoglycemia.
ABCs and rapid identification of easily reversible, life-threatening metabolic derangements take absolute precedence in any encephalopathic patient.
2
Administer empiric intravenous thiamine.
Thiamine levels are replenished.
This patient exhibits the classic triad of Wernicke encephalopathy (confusion, ataxia, nystagmus). Thiamine is a crucial cofactor for glucose metabolism and must be given before a heavy glucose load to prevent permanent neurological damage.
3
Administer intravenous dextrose.
The patient receives necessary glucose for cellular energy.
Following thiamine administration, dextrose is provided to correct potential hypoglycemia and support overall metabolic recovery.
4
Perform appropriate neuroimaging.
A non-contrast CT scan of the head is obtained.
Patients with severe alcohol use disorder are at high risk for traumatic brain injuries due to falls. Imaging is required to rule out structural pathology, but only after the patient is metabolically stabilized.

Anahtar Kavram

In patients with severe alcohol use disorder and altered mental status, acute management requires initial ABC stabilization, followed strictly by intravenous thiamine administration prior to or concurrently with intravenous dextrose, to prevent the precipitation or exacerbation of Wernicke encephalopathy.
Soru 796Soru →

A 23-year-old man is diagnosed with schizophrenia after presenting with a 7-month history of auditory hallucinations and disorganized behavior. His physician discusses the long-term management plan, noting that many patients require medication adjustments over their lifetime to achieve and maintain symptom remission. Arrange the following pharmacological interventions in the standard step-wise treatment algorithm for schizophrenia, from initial treatment of a first episode to the management of severe, treatment-refractory disease.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is to begin with an initial second-generation antipsychotic trial, followed by a switch to a second antipsychotic if the first fails, followed by clozapine for treatment resistance, and finally clozapine augmentation if symptoms remain refractory.
The established pharmacological algorithm for schizophrenia prioritizes a balance of safety and clinical efficacy. Initial therapy involves a single second-generation antipsychotic (SGA). If this first trial fails, a second monotherapy trial with a different SGA or a first-generation antipsychotic is indicated. Only if a patient fails two adequate trials do they meet the criteria for treatment-resistant schizophrenia, for which clozapine is the gold standard intervention. Finally, if clozapine monotherapy is insufficiently effective, augmentation with ECT, a mood stabilizer, or a supplementary antipsychotic is the appropriate subsequent step.

Adım Adım Çözüm

1
Identify the first-line treatment for a newly diagnosed patient.
Initiate a trial of an oral second-generation antipsychotic.
Second-generation antipsychotics are generally preferred as initial therapy due to a lower risk of extrapyramidal symptoms compared to first-generation agents.
2
Determine the next step if the first trial is unsuccessful.
Switch to a different first- or second-generation antipsychotic.
Before declaring a patient treatment-resistant, they must fail at least two different antipsychotic trials of adequate dose and duration.
3
Identify the treatment of choice for treatment-resistant schizophrenia.
Initiate clozapine monotherapy.
Clozapine is uniquely effective for treatment-resistant schizophrenia and is indicated only after two failed trials due to its risk of severe neutropenia and myocarditis.
4
Determine the management for clozapine-refractory disease.
Augment the regimen with electroconvulsive therapy (ECT) or a second antipsychotic.
When a patient fails to respond adequately to clozapine monotherapy, augmentation is the final established step in the algorithm.

Anahtar Kavram

The pharmacological algorithm for schizophrenia progresses from single antipsychotic trials to clozapine for treatment resistance (defined by the failure of 2 separate trials), followed by clozapine augmentation for refractory cases.
Soru 797Soru →

Match each patient presenting with major depressive disorder to the most appropriate first-line pharmacologic treatment based on their specific comorbidities and symptom profile.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 62-year-old man seeking psychiatric treatment one month after an acute myocardial infarction.
A 34-year-old man exhibiting severe fatigue, hypersomnolence, and expressing a strong desire to quit smoking.
A 28-year-old woman suffering from severe insomnia, poor appetite, and unwanted weight loss over the past two months.
A 41-year-old woman who has a history of poorly controlled diabetes and complains of burning, painful peripheral neuropathy.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Match the post-MI patient to Sertraline, the fatigued smoker to Bupropion, the patient with insomnia and weight loss to Mirtazapine, and the diabetic neuropathy patient to Duloxetine.
Each correct match utilizes the unique pharmacokinetic and pharmacodynamic properties of the antidepressants to simultaneously treat the patient's major depressive disorder and their specific comorbid symptoms, optimizing the therapeutic response while minimizing adverse effects.

Adım Adım Çözüm

1
Evaluate the 62-year-old man post-MI.
Identify the need for an antidepressant with high cardiovascular safety.
Post-MI patients are vulnerable to arrhythmias and drug interactions with cardiac medications; Sertraline is the safest evidence-based choice.
2
Evaluate the 34-year-old man with fatigue and smoking history.
Select Bupropion.
Bupropion's dopaminergic and noradrenergic effects counteract fatigue, and it independently aids in smoking cessation.
3
Evaluate the 28-year-old woman with insomnia and weight loss.
Select Mirtazapine.
Mirtazapine's adverse effects of weight gain and sedation are highly therapeutic for this specific clinical presentation.
4
Evaluate the 41-year-old woman with diabetic neuropathy.
Select Duloxetine.
SNRIs like Duloxetine treat both depression and neuropathic pain effectively through modulation of descending pain pathways.

Anahtar Kavram

Tailoring antidepressant therapy based on side-effect profiles and medical comorbidities.
Soru 798Soru →

A 48-year-old woman is evaluated in the outpatient psychiatry clinic at the insistence of her husband. For the past 9 months, she has been absolutely convinced that her neighbors are piping toxic gases into her home through the ventilation system to force her to move out. She has sealed all the vents in her house with duct tape and frequently sleeps in her car to "escape the fumes." She denies hearing voices, and her thoughts are otherwise logical and goal-directed. She continues to work successfully as a freelance graphic designer and maintains her close friendships, provided she does not discuss her neighbors. Her husband reports her mood has been generally stable, though she is understandably frustrated by the "gas attacks." Physical examination, neurological evaluation, and laboratory studies are unremarkable. Which of the following is the most accurate diagnosis for this patient?

Cevabı ve açıklamayı göster

Cevap: Delusional disorder

Cevap

Delusional disorder
The correct answer is Delusional disorder. This diagnosis requires the presence of one or more delusions for at least one month, without ever meeting the full criteria for schizophrenia (which requires at least two psychotic symptoms such as hallucinations, disorganized speech, or negative symptoms). Importantly, apart from the direct impact of the delusion itself, the patient's functioning is not markedly impaired, and her behavior is not obviously bizarre or odd. This patient has had a persistent persecutory delusion for 9 months but continues to work successfully and maintain friendships, which makes delusional disorder the most accurate diagnosis.

Adım Adım Çözüm

1
Analyze the core psychiatric symptom presented in the vignette.
The patient exhibits a fixed, false belief (that neighbors are poisoning her with gas) which represents a clear delusion.
Establishing the presence and type of psychosis is the first step in differentiating psychotic disorders.
2
Assess the timeline and the presence of any other psychotic or mood symptoms.
The delusion has been present for 9 months. There are no hallucinations, disorganized speech, disorganized behavior, or major mood episodes.
The duration of symptoms and the presence or absence of criteria A symptoms for schizophrenia strictly define the diagnostic categories.
3
Evaluate the patient's overall level of functioning.
Apart from the direct impact of the delusion (sleeping in her car, taping vents), her psychosocial and occupational functioning is remarkably preserved.
Schizophrenia requires a significant decline in functioning, whereas delusional disorder does not typically cause marked functional impairment outside the delusion.

Anahtar Kavram

Diagnosis of Delusional Disorder
Tahmini Süre:1m 0s
Soru 799Soru →

A 34-year-old woman is brought to the emergency department due to a sudden, severe, throbbing headache and blurred vision. Her symptoms began approximately one hour after she ingested an over-the-counter oral decongestant for a viral upper respiratory infection. Her medical history is significant for treatment-resistant atypical depression. After failing several medication trials, she was started on a new psychiatric medication four weeks ago, which has significantly improved her mood. Her temperature is 37.1°C (98.8°F), pulse is 118/min, and blood pressure is 225/125 mmHg. Physical examination reveals a diaphoretic, anxious patient in obvious distress. Neurologic examination demonstrates normal muscle tone, 2+ deep tendon reflexes globally, and absent clonus. Which of the following psychiatric medications was most likely prescribed to this patient?

Cevabı ve açıklamayı göster

Cevap: Phenelzine

Cevap

The correct answer is phenelzine, a monoamine oxidase inhibitor that can cause a hypertensive crisis when combined with sympathomimetic decongestants.
The correct answer is phenelzine. Phenelzine is a monoamine oxidase inhibitor (MAOI) often utilized for treatment-resistant or atypical depression. MAOIs irreversibly inhibit the degradation of monoamines, including norepinephrine. When a patient taking an MAOI is exposed to sympathomimetic medications (such as the pseudoephedrine commonly found in over-the-counter decongestants), the excessive accumulation of norepinephrine provokes a massive systemic sympathetic response. This drug-drug interaction precipitates a severe hypertensive crisis characterized by markedly elevated blood pressure, sudden throbbing headache, diaphoresis, and blurred vision. The absence of hyperthermia and neuromuscular irritability (such as clonus or hyperreflexia) critically distinguishes this crisis from serotonin syndrome.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation.
The patient is experiencing a sudden, severe hypertensive crisis (blood pressure 225/125 mmHg, severe headache) with autonomic symptoms but no neuromuscular hyperactivity.
Identifying the specific toxidrome is essential to narrow down the potential drug interactions.
2
Identify the precipitating trigger.
The symptoms began shortly after ingesting an over-the-counter oral decongestant (e.g., pseudoephedrine), which acts as a sympathomimetic agent.
Understanding the mechanism of the trigger helps deduce the underlying vulnerable state caused by the baseline medication.
3
Connect the trigger and presentation to the patient's psychiatric history.
The patient takes a medication for atypical depression. Monoamine oxidase inhibitors (MAOIs) like phenelzine are indicated for atypical depression and can cause a hypertensive crisis when interacting with sympathomimetics.
Synthesizing the interaction between the baseline medication class and the trigger confirms the diagnosis.

Anahtar Kavram

Monoamine oxidase inhibitors (MAOIs) can precipitate a life-threatening hypertensive crisis when combined with sympathomimetic agents (such as pseudoephedrine) due to excessive systemic norepinephrine accumulation.
Soru 800Soru →

Match each clinical presentation of a substance-related medical complication to the substance most likely responsible for the patient's condition.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 32-year-old man presents with acute chest pain, hypertension, and examination reveals perforation of the nasal septum.
A 24-year-old woman presents with severe dental caries, multiple facial excoriations, and delusions of parasitosis.
A 21-year-old man presents with cyclical, intractable vomiting and abdominal pain that is temporarily relieved by taking prolonged hot showers.
A 45-year-old man presents with a broad-based ataxic gait, bilateral abducens nerve palsy, and profound global confusion.
A 28-year-old man with needle track marks presents with high fever and multiple nodular cavitary lesions on a chest radiograph.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct pairings match each specific medical complication to its characteristic substance of abuse based on pathognomonic physical exam findings and history.
Each clinical scenario presents pathognomonic physical exam findings or medical sequelae that uniquely identify the underlying substance of abuse. Recognizing these distinct patterns is essential for accurate diagnosis and management in both emergency and primary care settings.

Adım Adım Çözüm

1
Analyze the patient with nasal septal perforation and chest pain.
This presentation is classically associated with cocaine use.
Cocaine causes intense local vasoconstriction, leading to ischemic necrosis of the nasal septum with chronic use. Acutely, it causes coronary vasospasm.
2
Analyze the patient with severe dental caries, facial excoriations, and delusions of parasitosis.
This matches methamphetamine use.
Chronic methamphetamine abuse results in 'meth mouth' (bruxism and poor dentition) and tactile hallucinations (formication), causing the patient to chronically pick at their skin.
3
Analyze the patient with cyclical vomiting relieved by hot showers.
This is pathognomonic for cannabinoid hyperemesis syndrome.
Long-term cannabis use can paradoxically cause severe recurrent vomiting, which patients learn to self-treat with compulsive exposure to hot water.
4
Analyze the patient with ataxia, abducens palsy, and confusion.
This triad indicates Wernicke encephalopathy, caused by chronic alcohol use.
Alcohol abuse leads to poor nutrition and thiamine (Vitamin B1) deficiency, presenting with the classic triad of encephalopathy, oculomotor dysfunction, and gait ataxia.
5
Analyze the patient with needle track marks and cavitary lung lesions.
This presentation points to intravenous heroin use.
Intravenous drug users are at high risk for tricuspid valve endocarditis (typically S. aureus), which showers the lungs with septic emboli, creating nodular cavitary lesions.

Anahtar Kavram

Medical complications of substance use disorders
ÖncekiSayfa 40 / 41Sonraki
Psychiatry Alıştırma Soruları — USMLE Step 2 CK — Sayfa 40 | Examkin